Working capital / assets moved 1386 bp lower
Working capital / assets changed -1386 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
42.54%→28.68%4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CVCO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory increased 20.4%
Inventory changed +20.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$258.4M→$311.1M4 prior comparisons
Current ratio decreased 28.5%
Current ratio changed -28.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
2.94→2.14 prior comparisons
Total assets increased 11.2%
Total assets changed +11.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$1.4B→$1.6B4 prior comparisons
Cash & equivalents decreased 27.5%
Cash & equivalents changed -27.5% from the comparable as-filed period.
$375.0M→$271.9M3 prior comparisons
Operating cash flow increased 22.9%
Operating cash flow changed +22.9% from the comparable as-filed period.
$78.5M→$96.4M3 prior comparisons
Capex / revenue moved 278 bp higher
Capex / revenue changed +278 basis points from the comparable as-filed period.
1.75%→4.53%2 prior comparisons
Revenue increased 17.9%
Revenue changed +17.9% from the comparable as-filed period.
$556.5M→$656.4M2 prior comparisons
Operating cash flow increased 34.1%
Operating cash flow changed +34.1% from the comparable as-filed period.
$55.5M→$74.5M2 prior comparisons
Cash & equivalents decreased 29.4%
Cash & equivalents changed -29.4% from the comparable as-filed period.
$344.6M→$243.2M2 prior comparisons
Operating margin moved 219 bp lower
Operating margin changed -219 basis points from the comparable as-filed period.
10.84%→8.65%2 prior comparisons
Capex / revenue moved 254 bp higher
Capex / revenue changed +254 basis points from the comparable as-filed period.
1.64%→4.18%2 prior comparisons
Operating income decreased 12.6%
Operating income changed -12.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$60.4M→$52.8M2 prior comparisons
Inventory / revenue moved 431 bp higher
Inventory / revenue changed +431 basis points from the comparable as-filed period.
46.34%→50.66%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.